Under the terms of the agreement, Midwinter will distribute Sun’s portfolio of both injectable and solid dose drugs. Midwinter will become the sole point of contact for all clinical trial supply enquiries and orders for these products.
Included within Sun’s portfolio are the drugs Gemcitabine, Carboplatin and Temozolomide, all of which are experiencing increasing usage in clinical trials.
Midwinter Director Ben Everington commented;
“Sun Pharmaceutical’s portfolio of drugs, along with their desire to help provide important supplies to clinical trials, is perfectly suited to Midwinter’s core capabilities. With Midwinter’s global network of customers we aim to increase Sun Pharmaceuticals exposure to this important market place, as well as strengthening Midwinter’s ability to offer unparalleled solutions for clinical trial supply”
Sun Pharmaceuticals Head of UK Hospital Supply, Jim McCarthy commented;
“Midwinter have a great reputation in their field, we are glad to partner with a company that can offer a responsive and dedicated to service to Sun Pharmaceuticals, our customers and most importantly the end user”back
10 Granary Wharf
global enquiries +44 (0)207 477 2229
© 2023 Midwinter Solutions - All Rights Reserved
Our website uses 7 main cookies. A cookie is a small file of letters and numbers that we put on your computer if you agree. These cookies allow us to distinguish you from other users of our website, which helps us to provide you with a good experience when you browse our website and also allows us to improve our site. The cookies we use are "analytical" cookies. They allow us to recognise and count the number of visitors and to see how visitors move around the site when they are using it. This helps us to improve the way our website works, for example by ensuring that users are finding what they are looking for easily. Read more about the individual cookies we use and how to recognise them by clicking here.
By clicking 'Accept', you agree to the storing of cookies on your device to enhance your browsing experience and for analytical purposes. By clicking ‘Reject’, only essential necessary cookies will be stored on your device.